Shortened Survival and Life Expectancy with a Diagnosis of Attention-Deficit and Hyperactivity Disorder (ADHD).

Q3 Medicine

Journal of insurance medicine (New York, N.Y.) Pub Date : 2025-10-09 DOI:10.17849/insm-52-3-1-4.1

John R Iacovino

引用次数: 0

Abstract

Mental health disorders are harder to evaluate for life insurance because their diagnoses can be subjective. To make fair decisions, insurance medical directors use research from trusted sources to calculate risk based on survival data. This article reviews a study conducted on patients in the UK with a diagnosis of attention-deficit and hyperactivity disorder (ADHD).

查看原文本刊更多论文

诊断为注意力缺陷和多动障碍（ADHD）的患者的生存和预期寿命缩短。

精神健康障碍更难评估，因为他们的诊断可能是主观的。为了做出公平的决定，保险公司的医疗主管使用可靠来源的研究来计算基于生存数据的风险。本文回顾了一项对英国诊断为注意力缺陷和多动障碍（ADHD）的患者进行的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of insurance medicine (New York, N.Y.) Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： The Journal of Insurance Medicine is a peer reviewed scientific journal sponsored by the American Academy of Insurance Medicine, and is published quarterly. Subscriptions to the Journal of Insurance Medicine are included in your AAIM membership.